Published in BMC Health Serv Res on January 11, 2009
Characteristics affecting oral anticoagulant therapy choice among patients with non-valvular atrial fibrillation: a retrospective claims analysis. BMC Health Serv Res (2014) 0.87
The Influence of Socioeconomic Status on Selection of Anticoagulation for Atrial Fibrillation. PLoS One (2016) 0.79
Factors affecting the uptake of new medicines: a systematic literature review. BMC Health Serv Res (2014) 0.77
Pharmaceutical cost control in primary care: opinion and contributions by healthcare professionals. BMC Health Serv Res (2009) 0.75
Danish physicians' preferences for prescribing escitalopram over citalopram and sertraline to treatment-naïve patients: a national, register-based study. Eur J Clin Pharmacol (2012) 0.75
The influence of hospital drug formulary policies on the prescribing patterns of proton pump inhibitors in primary care. Eur J Clin Pharmacol (2014) 0.75
Prescriber profile and post-marketing surveillance. Lancet (1993) 6.10
Monitoring health inequalities through general practice: the Second Dutch National Survey of General Practice. Eur J Public Health (2005) 5.33
The safety of newly approved medicines: do recent market removals mean there is a problem? JAMA (1999) 3.24
Changes in drug treatment after discharge from hospital in geriatric patients. BMJ (1992) 2.05
What happens to long-term medication when general practice patients are referred to hospital? Eur J Clin Pharmacol (1996) 1.86
Pharmaco-morbidity linkage: a feasibility study comparing morbidity in two pharmacy based exposure cohorts. J Epidemiol Community Health (1992) 1.81
A prescription for improvement? An observational study to identify how general practices vary in their growth in prescribing costs. BMJ (2000) 1.64
Prescribing new drugs: qualitative study of influences on consultants and general practitioners. BMJ (2001) 1.61
Physician and practice characteristics associated with the early utilization of new prescription drugs. Med Care (2003) 1.37
The influence of hospital-based prescribers on prescribing in general practice. Pharmacoeconomics (1999) 1.23
The safety of new medicines: the importance of asking the right questions. JAMA (1999) 1.07
A qualitative study to explore influences on general practitioners' decisions to prescribe new drugs. Br J Gen Pract (2003) 1.04
Shared help seeking behaviour within families: a retrospective cohort study. BMJ (2005) 1.03
Auditing GPs' prescribing habits: cardiovascular prescribing frequently continues medication initiated by specialists. Eur J Clin Pharmacol (1996) 0.87
The impact of specialists on prescribing by general practitioners. Med J Aust (2001) 0.87
Should rosuvastatin be withdrawn from the market? Lancet (2004) 0.85
The influence of specialists on prescribing by GPs. A qualitative study. Aust Fam Physician (2003) 0.84
FDA warns Merck over its promotion of rofecoxib. BMJ (2001) 0.80
The trade-off between cardiovascular and gastrointestinal effects of rofecoxib. Pharmacoepidemiol Drug Saf (2005) 0.78
Prescriber profile and postmarketing surveillance. Lancet (1993) 0.78
Channelling of controlled release formulation of ketoprofen (Oscorel) in patients with history of gastrointestinal problems. J Epidemiol Community Health (1992) 0.78
Patient characteristics associated with prescribing of a newly introduced drug: the case of rofecoxib. Eur J Clin Pharmacol (2005) 0.78
AstraZeneca digs in over advertising criticisms. BMJ (2004) 0.77
Green space, urbanity, and health: how strong is the relation? J Epidemiol Community Health (2006) 5.35
The breadth of primary care: a systematic literature review of its core dimensions. BMC Health Serv Res (2010) 4.78
Patient adherence to medical treatment: a review of reviews. BMC Health Serv Res (2007) 3.57
A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions. Pharmacoepidemiol Drug Saf (2002) 2.98
Rare essentials: drugs for rare diseases as essential medicines. Bull World Health Organ (2006) 2.81
Switching from originator brand medicines to generic equivalents in selected developing countries: how much could be saved? Value Health (2012) 2.50
The psychometric properties of the 'Hospital Survey on Patient Safety Culture' in Dutch hospitals. BMC Health Serv Res (2008) 2.40
Safety-related regulatory actions for biologicals approved in the United States and the European Union. JAMA (2008) 2.33
Social contacts as a possible mechanism behind the relation between green space and health. Health Place (2008) 2.31
The effectiveness of interventions using electronic reminders to improve adherence to chronic medication: a systematic review of the literature. J Am Med Inform Assoc (2012) 2.28
Hospitalisations and emergency department visits due to drug-drug interactions: a literature review. Pharmacoepidemiol Drug Saf (2007) 2.20
Physical activity as a possible mechanism behind the relationship between green space and health: a multilevel analysis. BMC Public Health (2008) 2.20
Multilevel modelling and public health policy. Scand J Public Health (2003) 2.11
Depressive symptoms in subjects with diagnosed and undiagnosed type 2 diabetes. Psychosom Med (2007) 2.09
Methods to assess intended effects of drug treatment in observational studies are reviewed. J Clin Epidemiol (2004) 2.03
Green space as a buffer between stressful life events and health. Soc Sci Med (2010) 1.96
QUALICOPC, a multi-country study evaluating quality, costs and equity in primary care. BMC Fam Pract (2011) 1.77
Association of risk of abnormal bleeding with degree of serotonin reuptake inhibition by antidepressants. Arch Intern Med (2004) 1.76
Fracture risk with intermittent high-dose oral glucocorticoid therapy. Arthritis Rheum (2007) 1.63
Design of a retrospective patient record study on the occurrence of adverse events among patients in Dutch hospitals. BMC Health Serv Res (2007) 1.61
International classification of diseases codes showed modest sensitivity for detecting community-acquired pneumonia. J Clin Epidemiol (2007) 1.58
Rate and determinants of 10-year persistence with antihypertensive drugs. J Hypertens (2005) 1.58
5-aminosalicylic acids and the risk of renal disease: a large British epidemiologic study. Gastroenterology (2004) 1.57
The Dutch consumer quality index: an example of stakeholder involvement in indicator development. BMC Health Serv Res (2010) 1.56
No increased risk of non-Hodgkin's lymphoma with steroids, estrogens and psychotropics (Netherlands). Cancer Causes Control (2003) 1.55
Is aspirin useful in patients on lithium? A pharmacoepidemiological study related to bipolar disorder. Prostaglandins Leukot Essent Fatty Acids (2009) 1.54
Effect of a pharmacist-led intervention on diuretic compliance in heart failure patients: a randomized controlled study. J Card Fail (2003) 1.50
You have to be there to enjoy it? Neighbourhood social capital and health. Eur J Public Health (2012) 1.50
Generic substitution of antihypertensive drugs: does it affect adherence? Ann Pharmacother (2005) 1.47
Availability of comparative trials for the assessment of new medicines in the European Union at the moment of market authorization. Br J Clin Pharmacol (2006) 1.43
Initiation of antidepressant therapy: do patients follow the GP's prescription? Br J Gen Pract (2009) 1.42
Measures of quality, costs and equity in primary health care instruments developed to analyse and compare primary care in 35 countries. Qual Prim Care (2013) 1.41
The inter-rater agreement of retrospective assessments of adverse events does not improve with two reviewers per patient record. J Clin Epidemiol (2009) 1.40
The association between antidepressant use and disturbances in glucose homeostasis: evidence from spontaneous reports. Eur J Clin Pharmacol (2008) 1.40
Use of health care services by ethnic minorities in The Netherlands: do patterns differ? Eur J Public Health (2006) 1.39
The role of patient safety culture in the causation of unintended events in hospitals. J Clin Nurs (2012) 1.38
Comparison of patient evaluations of health care quality in relation to WHO measures of achievement in 12 European countries. Bull World Health Organ (2004) 1.36
Comorbidity was associated with neurologic and psychiatric diseases: a general practice-based controlled study. J Clin Epidemiol (2006) 1.34
No increased incidence of diabetes in antidepressant users. Int Clin Psychopharmacol (2007) 1.33
The nature and causes of unintended events reported at ten emergency departments. BMC Emerg Med (2009) 1.33
Greenspace in urban neighbourhoods and residents' health: adding quality to quantity. J Epidemiol Community Health (2011) 1.32
Neighborhood social capital and individual health. Soc Sci Med (2010) 1.31
Using multilevel modeling to assess case-mix adjusters in consumer experience surveys in health care. Med Care (2009) 1.31
Traceability of biopharmaceuticals in spontaneous reporting systems: a cross-sectional study in the FDA Adverse Event Reporting System (FAERS) and EudraVigilance databases. Drug Saf (2013) 1.29
Differences between immigrant and non-immigrant groups in the use of primary medical care; a systematic review. BMC Health Serv Res (2009) 1.28
Effects of eHealth interventions on medication adherence: a systematic review of the literature. J Med Internet Res (2011) 1.27
How do healthcare consumers process and evaluate comparative healthcare information? A qualitative study using cognitive interviews. BMC Public Health (2009) 1.25
Incidence and determinants of long-term use of antidepressants. Eur J Clin Pharmacol (2004) 1.25
Nurse prescribing of medicines in Western European and Anglo-Saxon countries: a systematic review of the literature. BMC Health Serv Res (2011) 1.24
Definitions, variants, and causes of nonadherence with medication: a challenge for tailored interventions. Patient Prefer Adherence (2013) 1.24
Improving medication adherence in diabetes type 2 patients through Real Time Medication Monitoring: a randomised controlled trial to evaluate the effect of monitoring patients' medication use combined with short message service (SMS) reminders. BMC Health Serv Res (2011) 1.23
Effectiveness of interventions by community pharmacists to improve patient adherence to chronic medication: a systematic review. Ann Pharmacother (2005) 1.23
Nurse prescribing of medicines in Western European and Anglo-Saxon countries: a survey on forces, conditions and jurisdictional control. Int J Nurs Stud (2012) 1.23
Relationship of serotonergic antidepressants and need for blood transfusion in orthopedic surgical patients. Arch Intern Med (2003) 1.23
Exploring the black box of quality improvement collaboratives: modelling relations between conditions, applied changes and outcomes. Implement Sci (2009) 1.22
Tracking the spatial diffusion of influenza and norovirus using telehealth data: a spatiotemporal analysis of syndromic data. BMC Med (2008) 1.22
The risk of fracture in patients with multiple sclerosis: the UK general practice research database. J Bone Miner Res (2011) 1.22
Developing and testing an instrument to measure the presence of conditions for successful implementation of quality improvement collaboratives. BMC Health Serv Res (2008) 1.21
Translation of rare disease research into orphan drug development: disease matters. Drug Discov Today (2009) 1.21
Furthering patient adherence: a position paper of the international expert forum on patient adherence based on an internet forum discussion. BMC Health Serv Res (2008) 1.21
Public trust in health care: a comparison of Germany, The Netherlands, and England and Wales. Health Policy (2006) 1.21
In-hospital cardiac arrest is associated with use of non-antiarrhythmic QTc-prolonging drugs. Br J Clin Pharmacol (2006) 1.19
Factors influencing non-approval of new drugs in Europe. Nat Rev Drug Discov (2012) 1.18
Characteristics of orphan drug applications that fail to achieve marketing approval in the USA. Drug Discov Today (2010) 1.18
Prescription of respiratory medication without an asthma diagnosis in children: a population based study. BMC Health Serv Res (2008) 1.16
Determinants of the range of drugs prescribed in general practice: a cross-sectional analysis. BMC Health Serv Res (2007) 1.16
Patient risk profiles and practice variation in nonadherence to antidepressants, antihypertensives and oral hypoglycemics. BMC Health Serv Res (2007) 1.16
Predictors of orphan drug approval in the European Union. Eur J Clin Pharmacol (2008) 1.16
Risk of aplastic anemia in patients using antiepileptic drugs. Epilepsia (2006) 1.12
Impact of over-the-counter restrictions on antibiotic consumption in Brazil and Mexico. PLoS One (2013) 1.11
Antibiotics for respiratory, ear and urinary tract disorders and consistency among GPs. J Antimicrob Chemother (2008) 1.11
Evaluation of the clinical value of pharmacists' modifications of prescription errors. Br J Clin Pharmacol (2004) 1.10
Bringing a European perspective to the health human resources debate: A scoping study.. Health Policy (2012) 1.10
Understanding organisational development, sustainability, and diffusion of innovations within hospitals participating in a multilevel quality collaborative. Implement Sci (2011) 1.10
Accuracy of diagnosing depression in primary care: the impact of chronic somatic and psychiatric co-morbidity. Psychol Med (2005) 1.08
Quality of patient record keeping: an indicator of the quality of care? BMJ Qual Saf (2011) 1.07
Association of nonsteroidal anti-inflammatory drugs with first occurrence of heart failure and with relapsing heart failure: the Rotterdam Study. Arch Intern Med (2002) 1.07
The Dutch health insurance reform: switching between insurers, a comparison between the general population and the chronically ill and disabled. BMC Health Serv Res (2008) 1.07
Streetscape greenery and health: stress, social cohesion and physical activity as mediators. Soc Sci Med (2013) 1.06
Association between antidepressant drug use and hyponatraemia: a case-control study. Br J Clin Pharmacol (2002) 1.06
Health-related behavior as a mechanism behind the relationship between neighborhood social capital and individual health--a multilevel analysis. BMC Public Health (2012) 1.06
Moral hazard and supplier-induced demand: empirical evidence in general practice. Health Econ (2012) 1.05
Why are some medical specialists working part-time, while others work full-time? Health Policy (2005) 1.05
Statins, systemic inflammation and risk of death in COPD: the Rotterdam study. Pulm Pharmacol Ther (2012) 1.04
Reimbursement restriction and moderate decrease in benzodiazepine use in general practice. Ann Fam Med (2012) 1.04
The effect of pharmacotherapy audit meetings on early new drug prescribing by general practitioners. Ann Pharmacother (2007) 1.03
Incidence of fractures in patients with multiple sclerosis: the Danish National Health Registers. Mult Scler (2011) 1.03